Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis

Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, Jean-François Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco
European Respiratory Journal 2015 46: PA847; DOI: 10.1183/13993003.congress-2015.PA847
Serge Lebecque
1UCBLyon1, INSERM 1052/CNRS 5286, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toufic Renno
2UCBLyon1, INSERM 1052, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azzak Bentaher
3CIRI, INSERM 1111, Pierre Benite, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marine Ponchon
4CIRI, INSERM 1111, Pierre Benite, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Calender
5CNRS 1462, UCBLyon1, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-François Bernaudin
6APHP, CHU Tenon, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Valeyre
7APHP, CHU Avicenne, Bobigny, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Iglarz
8Actelion Pharma, Actelion, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herve Farine
9Actelion Pharma, Actelion, Allschwil, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Strasser
10Actelion Pharma, Actelion, Allschwil, Swaziland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Pacheco
11UCBLyon1, INSERM 1111, Pierre Benite, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: Nanoparticles are increasingly suspected as a strong etiologic factor in sarcoidosis pathogenesis.The aim of our study was to evaluate lung inflammatory response and histology changes following exposure of mice to two types of nanoparticles: carbon nanotubes (MWCNT) and cadmium-based nanoparticles (QDOT705) in order to better our understanding of human sarcoidosis.

Material and methods: Various groups of mice were included: control mice received PBS or Complete Freund's adjuvant, and mice that received PBS or Complete Freund's adjuvant were intranasally exposed to QDOTs or MWCNT. One month later, blood and bronchoalveolar lavages (BAL) were collected for cell counts and cytokine profile and lung tissues processed for histology and immunostaining studies.

Results: We observed: 1) higher BAL cellularity compared to controls; 2) increased numbers of neutrophils, macrophages and lymphocytes; 3) high CXCL9 and CXCL10 levels; 3) heterogeneous areas with increased cellular infiltrates and granuloma surfaces; 4) CD3+ T and B cells cells infiltration in inflammatory areas; 4) up-regulated mediators: CXCL2, CCR1 and IL6 (inflammatory cell recruitment); CCR5 (TH1 recruitment and maturation); IL6 and IL23A (TH17 maturation); CXCL15 and IL13 (bronchial cell activation and hyper-reactivity); TLR2 and TLR9 (innate immunity). Of relevance, these mouse data correlate with those observed in human sarcoidosis.

Conclusions: our mouse model describes the initial inflammatory and histological processes in response to nanoparticles that mimics “pre-granulomatous“ lesions and mediator production, which are important steps in paving the way for sarcoidosis development in humans.

  • Animal models
  • Inflammation
  • Chronic disease
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, Jean-François Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco
European Respiratory Journal Sep 2015, 46 (suppl 59) PA847; DOI: 10.1183/13993003.congress-2015.PA847

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, Jean-François Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco
European Respiratory Journal Sep 2015, 46 (suppl 59) PA847; DOI: 10.1183/13993003.congress-2015.PA847
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
  • Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Show more 1.5 Diffuse Parenchymal Lung Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society